GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Dimerix DXB.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.22

+7.32%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2026

Revenue

A$4.4m

FY2017FY2026

Net income

−A$29.8m

FY2017FY2026

Free cash flow

−A$51.8m

FY2017FY2026

Shareholders' equity

−A$14.8m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueA$4.4mA$1.3mA$583,478A$36,787A$6.5mA$4.4mA$2.3mA$1.4mA$845,288A$554,617
Gross profitA$4.2mA$1.3mA$583,478A$36,787A$6.4mA$4.4mA$2.3mA$1.4mA$838,866A$553,097
Research and developmentA$36.0mA$27.3mA$21.1mA$20.5mA$14.4mA$9.3mA$5.5mA$2.8mA$2.1mA$878,118
Operating income−A$37.2m−A$36.3m−A$25.2m−A$22.8m−A$10.5m−A$10.9m−A$6.9m−A$4.3m−A$4.2m−A$2.3m
Net income−A$29.8m−A$13.3m−A$17.1m−A$13.8m−A$10.5m−A$6.4m−A$4.5m−A$2.9m−A$3.3m−A$1.8m
Diluted earnings per share-0.05-0.02-0.03-0.03-0.03-0.02-0.02-0.02-0.02-0.02

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsA$58.6mA$91.2mA$32.1mA$17.8mA$16.5mA$9.4mA$10.4mA$4.9mA$7.3mA$2.9m
Cash and short-term investmentsA$16.2mA$68.3mA$22.1mA$8.0mA$9.6mA$5.3mA$7.8mA$3.6mA$6.3mA$2.2m
Total liabilitiesA$73.3mA$77.8mA$13.9mA$11.8mA$2.1mA$8.0mA$2.6mA$737,768A$406,744A$242,118
DebtA$232,091A$97,481A$149,683A$6.0mA$73,099A$5.1mA$1.1mA$1.1m——
Shareholders' equity−A$14.8mA$13.4mA$18.2mA$6.0mA$14.4mA$1.5mA$7.8mA$4.2mA$6.9mA$2.6m
Shares outstanding600m600m555m406m327m273m201m165m158m92m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−A$51.8mA$39.1m−A$7.0m−A$12.7m−A$13.4m−A$6.5m−A$4.7m−A$2.8m−A$3.2m−A$1.9m
Capital spending−A$4,983−A$21,006−A$15,798−A$2,299−A$10,614−A$9,572−A$9,572−A$6,906−A$3,543−A$2,581
Free cash flow−A$51.8mA$39.0m−A$7.0m−A$12.7m−A$13.4m−A$6.5m−A$4.7m−A$2.8m−A$3.2m−A$1.9m
Dividends paid———−A$10.7m−A$1,398−A$1.2m−A$8.5m———

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Mar 2025Dec 2024Jun 2024Dec 2023Jun 2023
RevenueA$2.2mA$2.1mA$5.3mA$36,534A$287,450A$450,418A$133,060A$9.0m
Gross profit——A$5.3mA$36,534A$287,450A$450,418A$133,060A$9.0m
Operating income−A$15.4m−A$21.7m−A$18.9m−A$200,908−A$13.1m−A$18.3m−A$6.8m−A$13.1m
Net income−A$13.8m−A$16.0m−A$344,324−A$263,989−A$12.9m−A$10.4m−A$6.7m−A$4.2m
Diluted earnings per share-0.02-0.03-0.00-0.00-0.02-0.02-0.02-0.01
Cash from operations−A$21.0m−A$29.0mA$41.0m—−A$2.0m−A$16.0mA$9.0m−A$8.0m
Total assetsA$58.6mA$64.6mA$91.2m—A$21.9mA$32.1mA$15.1mA$17.8m
Cash and short-term investmentsA$16.2mA$38.5mA$68.3m—A$21.1mA$22.1mA$14.8mA$8.0m
DebtA$124,088A$33,418A$97,481—A$156,417A$229,854A$1.4mA$6.0m
Shareholders' equity−A$14.8m−A$1.7mA$13.4m—A$7.2mA$18.2mA$1.7mA$6.0m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue390.8%-0.4%21.7%
Operating income17.7%27.7%34.7%
Net income29.3%36.2%19.0%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin97.5%97.8%98.6%98.9%
Operating margin-1311.7%-1953.0%-834.9%-709.3%
Net margin-768.3%-1187.8%-530.2%-473.3%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-4.2-15.3-6.8-3.7-2.7-6.3-6.4-1.7-0.9-1.5
Price to sales29.0161.9198.9—4.49.112.23.33.84.6

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 24 Sept 1999.

FY2000FY1999
Paid in the year5.46947.031
  • 20-to-1 reverse split · 23 Oct 2017
  • 14-to-1 reverse split · 4 Oct 2012
  • 5-to-2 reverse split · 24 Jan 2005
  • 5-for-1 split · 3 Jul 1992

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.